The 2016 All-Europe Research Team: Small- & Midcapitalization Stocks, No. 1: Eduardo Lecubarri & team
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The 2016 All-Europe Research Team: Small- & Midcapitalization Stocks, No. 1: Eduardo Lecubarri & team

2016-02-tom-johnson-all-europe-research-team-eduardo-lecubarri-small.jpg

As it has done for the past two years, J.P. Morgan Cazenove earns first-place honors for its coverage of Europe’s small- and micap stocks.

< The 2016 All-Europe Research Team

2016-02-tom-johnson-all-europe-research-team-eduardo-lecubarri.jpg

Eduardo Lecubarri & team

J.P. Morgan Cazenove

First-Place Appearances: 4


Total Appearances: 8


Team Debut: 2009


As it has done for the past two years, J.P. Morgan Cazenove earns first-place honors for its coverage of Europe’s small- and micap stocks. The firm’s London- and Mumbai-based trio led by Eduardo Lecubarri is applauded by one fund manager for its “systematic approach to the space. It has a great methodology, comparable between regions, and is always updated.” Lecubarri, 42, believes that there is not “a single issue that ever drives the market,” so the analysts instead use their proprietary strategy framework to analyze companies. Currently, they are favoring names “with attractive valuations, strong balance sheets with which to boost shareholder returns and no operating downside,” he reports. Companies that pass the researchers’ screen include: Atresmedia Corp. de Medios de Comunicación, a Spanish media group; British residential property developer Bellway; Mediaset España Comunicación, Spain’s largest television network; Randstad Holding, a Dutch human resources provider; U.K.-based drinks company Stock Spirits Group, which operates in Central and Eastern Europe; Salzgitter, one of Germany’s largest steel producers; and Vectura Group, a U.K. drugmaker. Lecubarri “should be managing a fund,” declares a second admirer. “He makes money year after year.”



Gift this article